Tags

Type your tag names separated by a space and hit enter

Population immunity to measles in the United States, 1999.
J Infect Dis. 2004 May 01; 189 Suppl 1:S91-7.JI

Abstract

To estimate population immunity, we examined measles immunity among residents of the United States in 1999 from serological and vaccine coverage surveys. For persons aged >or=20 years, serological data from the third National Health and Nutrition Examination Survey (1988-1994) were used. For persons <20 years of age, immunity was estimated from results of the National Immunization Survey (1994-1998), state surveys of school entrants (1990-2000), and vaccine coverage surveys of adolescents (1997). To estimate immunity from vaccine coverage data, 95% vaccine efficacy was used for recipients of a single dose at >or=12 years of age and 99% vaccine efficacy was used for those with failure of a first dose who were revaccinated. Overall, calculated population immunity was found to be 93%. Although there was not much variation in immunity by region and state, in some large urban centers immunity among preschool-aged children was as low as 86%. Overall, geographic- and age-specific estimates of a high population immunity support the epidemiological evidence that measles disease is no longer endemic in the United States.

Authors+Show Affiliations

National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. ssh1@cdc.gov.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15106096

Citation

Hutchins, Sonja S., et al. "Population Immunity to Measles in the United States, 1999." The Journal of Infectious Diseases, vol. 189 Suppl 1, 2004, pp. S91-7.
Hutchins SS, Bellini WJ, Coronado V, et al. Population immunity to measles in the United States, 1999. J Infect Dis. 2004;189 Suppl 1:S91-7.
Hutchins, S. S., Bellini, W. J., Coronado, V., Jiles, R., Wooten, K., & Deladisma, A. (2004). Population immunity to measles in the United States, 1999. The Journal of Infectious Diseases, 189 Suppl 1, S91-7.
Hutchins SS, et al. Population Immunity to Measles in the United States, 1999. J Infect Dis. 2004 May 1;189 Suppl 1:S91-7. PubMed PMID: 15106096.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Population immunity to measles in the United States, 1999. AU - Hutchins,Sonja S, AU - Bellini,William J, AU - Coronado,Victor, AU - Jiles,Ruth, AU - Wooten,Karen, AU - Deladisma,Adeline, PY - 2004/4/24/pubmed PY - 2004/6/16/medline PY - 2004/4/24/entrez SP - S91 EP - 7 JF - The Journal of infectious diseases JO - J Infect Dis VL - 189 Suppl 1 N2 - To estimate population immunity, we examined measles immunity among residents of the United States in 1999 from serological and vaccine coverage surveys. For persons aged >or=20 years, serological data from the third National Health and Nutrition Examination Survey (1988-1994) were used. For persons <20 years of age, immunity was estimated from results of the National Immunization Survey (1994-1998), state surveys of school entrants (1990-2000), and vaccine coverage surveys of adolescents (1997). To estimate immunity from vaccine coverage data, 95% vaccine efficacy was used for recipients of a single dose at >or=12 years of age and 99% vaccine efficacy was used for those with failure of a first dose who were revaccinated. Overall, calculated population immunity was found to be 93%. Although there was not much variation in immunity by region and state, in some large urban centers immunity among preschool-aged children was as low as 86%. Overall, geographic- and age-specific estimates of a high population immunity support the epidemiological evidence that measles disease is no longer endemic in the United States. SN - 0022-1899 UR - https://www.unboundmedicine.com/medline/citation/15106096/Population_immunity_to_measles_in_the_United_States_1999_ DB - PRIME DP - Unbound Medicine ER -